predicting manipulating cardiac drug inactivation human gut bacterium eggerthella lenta 
despite numerous examples effects human gastrointestinal microbiome drug efficacy toxicity often incomplete understanding underlying mechanisms dissect inactivation cardiac drug digoxin gut actinobacterium eggerthella lenta transcriptional profiling comparative genomics culture-based assays revealed cytochrome-encoding operon up-regulated digoxin inhibited arginine absent nonmetabolizing e lenta strains predictive digoxin inactivation human gut microbiome pharmacokinetic studies using gnotobiotic mice revealed dietary protein reduces vivo microbial metabolism digoxin significant changes drug concentration serum urine results emphasize importance viewing pharmacology perspective human microbial genomes 
